CClinicalTrials.gg
CompletedNCT02839824CALICOLUpdated Jan 26, 2018

Evaluation of the Quality of Bowel Cleansing in a Real Clinical Practice Setting

An observational study in Bowel Preparation for Colonoscopy, sponsored by Casen Recordati S.L.. Completed at 1 site in Spain. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2018-01-26.

Sponsored by Casen Recordati S.L. · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
412
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Publications of the use of bowel cleansers in usual clinical practice are lacking. Patient adherence to investigational products increases in the context of clinical trials. By the same token, efficacy of interventions may be overestimated in clinical trials.

For this reason, an observational study to collect data on the effectiveness of several colonic preparations when these are used under usual clinical practice is proposed.

02

Conditions studied

  • Bowel Preparation for Colonoscopy

Keywords

  • bowel cleansing
  • bowel preparation
03

In context

Lead sponsor

Casen Recordati S.L. is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients who have been performed a colonoscopy and who have received a bowel cleansing agent according to the investigator criteria

Inclusion criteria

  • Age 18-80 years
  • Subjects who have been performed a colonoscopy

Exclusion criteria

Exclusion Criteria:

  • Subjects being previously performed colon surgery.
  • Subjects suffering from active inflammatory bowel disease at the time of performing colonoscopy.
  • Subjects with extreme limitations due to disease.
  • Subjects in who Boston Bowel Preparation Scale (BBPS) is not available
  • Subjects who have undergone a colonoscopy during their participation in another clinical study.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
412 participants (actual)
Patient registry
No

Interventions

  • ProcedureBowel preparation

    Bowel preparation for bowel cleansing in a real clinical practice

06

What researchers measure

Primary outcomes

  1. Percentage of patients with adequate colon cleansing

    Percentage of patients with punctuation in Boston bowel preparation scale (BBPS) ≥ 5

    Time frame: Through study completion, an average of 6 months

Secondary outcomes

  1. Percentage of patients with adequate colon cleansing of different administration schedules

    Percentage of patients with punctuation in BBPS ≥ 5 in each administration schedule

    Time frame: Through study completion, an average of 6 months

  2. Identify factors influencing bowel cleansing quality

    Relationship between BBPS ≥ 5 and age, gender, ethnicity, weight, height, tobacco consumption, concomitant diseases, medications and indication for colonoscopy in a multivariate analysis.

    Time frame: Through study completion, an average of 6 months

  3. Influence of total volume of liquid ingestion in the effectiveness of bowel cleansing agents

    Relationship between BBPS ≥ 5and the volume of liquid ingestion

    Time frame: Through study completion, an average of 6 months

  4. Patients' tolerance

    Percentage of each adverse event reported per patient in each administration schedule

    Time frame: Through study completion, an average of 6 months

  5. Quality of bowel cleansing comparison among different bowel cleansing agents

    Comparison of percentage of patients with BBPS ≥ 5 between different bowel cleansing agents

    Time frame: Through study completion, an average of 6 months

  6. Subjects' satisfaction

    Comparison of subjects' satisfaction between different bowel cleansing agents with a five point likert scale

    Time frame: Through study completion, an average of 6 months

07

Study locations

1 site
  • Clínica de Medicina Integral Diagonal
    Esplugues de Llobregat, Barcelona 08950, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 26, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02839824
Lead sponsor
Casen Recordati S.L.
Responsible party
Sponsor
First posted
Jul 21, 2016
Start date
Sep 15, 2016
Primary completion
Mar 6, 2017
Completion
Mar 6, 2017
Last update
Jan 26, 2018

Study contacts

Ana Bargalló, MD
study director · Clínica de Medicina Integral Diagonal, Gastroenterology department

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion